TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 94 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,417,341 | -38.5% | 878,199 | +7.0% | 0.00% | – |
| Q2 2023 | $7,181,318 | +409.5% | 820,722 | +589.5% | 0.00% | – |
| Q1 2023 | $1,409,422 | +16.3% | 119,039 | -0.0% | 0.00% | – |
| Q4 2022 | $1,212,174 | +388.8% | 119,074 | +183.3% | 0.00% | – |
| Q3 2022 | $248,000 | +406.1% | 42,037 | +111.9% | 0.00% | – |
| Q2 2022 | $49,000 | -89.9% | 19,837 | -87.8% | 0.00% | – |
| Q1 2022 | $485,000 | -57.6% | 163,237 | +0.8% | 0.00% | – |
| Q4 2021 | $1,145,000 | -26.9% | 162,019 | +7.8% | 0.00% | – |
| Q3 2021 | $1,567,000 | -0.7% | 150,340 | +16.8% | 0.00% | – |
| Q2 2021 | $1,578,000 | -27.3% | 128,703 | +30.5% | 0.00% | – |
| Q1 2021 | $2,170,000 | – | 98,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |